Abstract
The review article presents data on the management of lipid storage disease in patients with diabetes mellitus (DM). A clinical case of a patient with diabetes and high cardiovascular risk caused by severe hyperlipidemia among other things is provided for illustrative purposes. The article reviews the results of clinical studies of the efficacy and safety of Pitavastatin in patients with cardiometabolic disorders. The dynamics of the lipid spectrum and glycaemia indicators against the background of course therapy with Pitavastatin at a daily dose of 4 mg in combination with the diet therapy is monitored in patients with diabetes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
